Novo Nordisk(MX:NOVOBN)
MX$745.000.00 (0.00%)
MX:NOVOBN
Novo Nordisk earnings date
MX$745.00
At close:0.00 (0.00%)
Novo Nordisk (NOVOBN) Q2 2023 Earnings Report
2 Followers
MX:NOVOBN Q2 2023 EPS Results
- Actual EPS
- MXN 11.99
- Consensus EPS
- MXN 12.73
- Beat/Miss
- Missed by -MXN 0.74
- One Year Ago EPS
- MXN 8.14
MX:NOVOBN Q2 2023 Revenue Results
- Actual Revenue
- MXN 150.86B
- Expected Revenue
- MXN 154.11B
- Beat/Miss
- Missed by -MXN 3.24B
- YoY Revenue Growth
- +31.59%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/10/2023
- Time
- Before Open
- Conference Call
- Thursday, August 10, 2023
MX:NOVOBN Upcoming Earnings
Novo Nordisk's next earnings date is estimated for February 3, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:NOVOBN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 03, 2027 | 2026 (Q4) | 12.53- | 16.78 | ― | ― |
| Nov 04, 2026 | 2026 (Q3) | 13.2116.09 | 12.5 | 28.67% (+3.58) | |
| Aug 04, 2026 | 2026 (Q2) | 13.9817.17 | 16.56 | 3.69% (+0.61) | |
| May 06, 2026 | 2026 (Q1) | 16.6618.42 | 18.14 | 1.53% (+0.28) | |
| Feb 03, 2026 | 2025 (Q4) | 16.3216.78 | 17.61 | -4.73% (-0.83) | |
| Nov 05, 2025 | 2025 (Q3) | 13.6112.50 | 17 | -26.47% (-4.50) | |
| Aug 06, 2025 | 2025 (Q2) | 16.4816.56 | 12.47 | 32.74% (+4.08) | |
| May 07, 2025 | 2025 (Q1) | 16.9618.14 | 15.78 | 14.96% (+2.36) | |
| Feb 05, 2025 | 2024 (Q4) | 16.6117.61 | 13.64 | 29.12% (+3.97) | |
| Nov 06, 2024 | 2024 (Q3) | 16.6617.00 | 13.89 | 22.40% (+3.11) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
